In patients with type 2 diabetes and CKD, finerenone improved CV and kidney outcomes.

Mayne KJ., Herrington WG.

Source citationAgarwal R, Filippatos G, Pitt B, et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J. 2022;43:474-84. 35023547.

DOI

10.7326/j22-0029

Type

Journal article

Journal

Annals of internal medicine

Publication Date

03/05/2022

Volume

175

Addresses

University of Oxford, Oxford, Oxfordshire, England, UK (K.J.M., W.G.H.).

Keywords

Kidney, Humans, Diabetes Mellitus, Type 2, Naphthyridines, Renal Insufficiency, Chronic

Permalink Original publication